Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-8-11
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1613-2246
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
364-6
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20700811-Aged, 80 and over, pubmed-meshheading:20700811-Angiogenesis Inhibitors, pubmed-meshheading:20700811-Antibodies, Monoclonal, pubmed-meshheading:20700811-Antibodies, Monoclonal, Humanized, pubmed-meshheading:20700811-Choroid, pubmed-meshheading:20700811-Choroid Diseases, pubmed-meshheading:20700811-Combined Modality Therapy, pubmed-meshheading:20700811-Fluorescein Angiography, pubmed-meshheading:20700811-Glucocorticoids, pubmed-meshheading:20700811-Humans, pubmed-meshheading:20700811-Injections, pubmed-meshheading:20700811-Male, pubmed-meshheading:20700811-Peripheral Vascular Diseases, pubmed-meshheading:20700811-Photochemotherapy, pubmed-meshheading:20700811-Retinal Perforations, pubmed-meshheading:20700811-Tomography, Optical Coherence, pubmed-meshheading:20700811-Triamcinolone Acetonide, pubmed-meshheading:20700811-Vascular Endothelial Growth Factor A, pubmed-meshheading:20700811-Vitreous Body
pubmed:year
2010
pubmed:articleTitle
Macular hole formation following photodynamic therapy combined with intravitreal injection of bevacizumab and triamcinolone acetonide.
pubmed:publicationType
Letter, Case Reports